Stay updated on Finerenone and Empagliflozin Combination in CKD Clinical Trial
Sign up to get notified when there's something new on the Finerenone and Empagliflozin Combination in CKD Clinical Trial page.

Latest updates to the Finerenone and Empagliflozin Combination in CKD Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new revision entry v3.5.4 is added to the record history, replacing the previous v3.5.3. This reflects an updated version of the study record in the history timeline.SummaryDifference0.1%

- Check20 days agoChange DetectedThe References entry was removed from a version in the Study Record History, reducing visibility of sources cited for that version. The rest of the version details remain unchanged.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page’s revision/version label was updated from v3.5.2 to v3.5.3, indicating a minor technical release with no visible change to the study record history content.SummaryDifference0.1%

- Check41 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the history.SummaryDifference0.1%

- Check55 days agoChange DetectedNew study data sections have been added to the history, including Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and related document sections. The record now shows a 2026-03-27 return with Quality Control Review status (Has Not Concluded).SummaryDifference0.8%

- Check70 days agoChange DetectedFooter now shows Revision: v3.5.0, replacing Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Finerenone and Empagliflozin Combination in CKD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Finerenone and Empagliflozin Combination in CKD Clinical Trial page.